The stock of Viking Therapeutics Inc (NASDAQ:VKTX) last traded at $66.14, down -0.74% from the previous session.
VKTX stock price is now 21.47% away from the 50-day moving average and 41.05% away from the 200-day moving average. The market capitalization of the company currently stands at $7.33B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $105, Morgan Stanley recently initiated with Overweight rating for Viking Therapeutics Inc (NASDAQ: VKTX). On May 16, 2024, Raymond James Upgraded its previous ‘Outperform’ rating to ‘Strong Buy’ on the stock increasing its target price from $115 to quote $116, while ‘Oppenheimer’ rates the stock as ‘Outperform’
In other news, Lian Brian, President & CEO sold 112,870 shares of the company’s stock on Aug 19 ’24. The stock was sold for $7,426,508 at an average price of $65.80. Upon completion of the transaction, the President & CEO now directly owns 2,354,927 shares in the company, valued at $155.75 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 19 ’24, Director SINGLETON J MATTHEW sold 16,000 shares of the business’s stock. A total of $995,453 was realized by selling the stock at an average price of $62.22. This leaves the insider owning 9,500 shares of the company worth $0.63 million. A total of 6.55% of the company’s stock is owned by insiders.
During the past 12 months, Viking Therapeutics Inc has had a low of $8.28 and a high of $99.41. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 37.69, and a quick ratio of 37.69. The fifty day moving average price for VKTX is $54.6514 and a two-hundred day moving average price translates $47.17555 for the stock.
The latest earnings results from Viking Therapeutics Inc (NASDAQ: VKTX) was released for 2024-06-30.
